In a recent article in CIO Insight, new tranSMART Foundation Silver Member Rancho Biosciences’ CEO Julie Bryant was interviewed about the pharma industry, Rancho and their involvement in tranSMART. Julie also discusses her partnership with another new Foundation Silver Member, British Telecom.
Rancho BioSciences, a provider of data curation services for the pharmaceutical industry, turns to the cloud to deliver model performance. Big data and analytics are at the heart of today’s biosciences and pharmaceutical industries. The ability to crunch numbers and understand complex equations is critical. But building an IT environment that can deliver massive processing power and accommodate storage and other requirements is nothing less than daunting. “There are sometimes terabytes of data to deal with and the ability to process data rapidly and efficiently is extremely important,” said Julie Bryant, CEO at Rancho BioSciences, a San Diego, Calif., firm that handles sophisticated data analysis for genomic and clinical data sets. As a result, Rancho BioSciences has partnered with British Telecom (BT) to deliver a cloud-based IT infrastructure that’s robust enough to address the needs of customers. The infrastructure-as-a-service (IaaS) platform, which incorporates an open-source data analytics platform called tranSmart (managed by the tranSmart Foundation and founded by Johnson & Johnson in 2009) offers an environment that keeps the company at the leading edge of scientific data analysis.